Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2011-10-20 17:40 |
VIVALIS: Growth momentum remains strong with third quarter revenues up 150%
|
English | 101.0 KB | ||
| 2011-10-20 17:40 |
VIVALIS :Poursuite de la forte dynamique de croissance avec une hausse du chiff…
|
French | 98.1 KB | ||
| 2011-10-18 17:40 |
VIVALIS ET GEOVAX SIGNENT UN ACCORD DE BIOPRODUCTION POUR LA PRODUCTION DE VAC…
|
French | 99.5 KB | ||
| 2011-10-18 17:40 |
VIVALIS AND GEOVAX ENTER INTO A BIOMANUFACTURING AGREEMENT FOR THE PRODUCTION O…
|
English | 224.5 KB | ||
| 2011-10-06 18:32 |
VIVALIS ACTIONS ET DROITS DE VOTE
|
English | 7.2 KB | ||
| 2011-10-04 17:40 |
VIVALIS AND DELTA-VIR ENTER IN A COMMERCIAL AGREEMENT TO MANUFACTURE NEWCASTLE …
|
English | 143.5 KB | ||
| 2011-10-04 17:40 |
VIVALIS ET DELTA-VIR SIGNENT UN ACCORD COMMERCIAL POUR PRODUIRE SUR LA PLATEFOR…
|
French | 81.4 KB | ||
| 2011-09-21 17:40 |
VIVALIS TO PRESENT AT JEFFERIES 2011 GLOBAL HEALTHCARE CONFERENCE IN LONDON
|
English | 80.1 KB | ||
| 2011-09-21 17:40 |
VIVALIS PARTICIPERA AU GLOBAL HEALTHCARE CONFERENCE ORGANISE PAR JEFFERIES A LO…
|
French | 87.4 KB | ||
| 2011-09-15 17:40 |
Vivalis to participate in Midcap Event on 22 & 23 September 2011
|
English | 83.9 KB | ||
| 2011-09-15 17:40 |
Vivalis participera au Midcap Event les 22 et 23 septembre 2011
|
French | 88.4 KB | ||
| 2011-09-06 17:40 |
VIVALIS ET SES LICENCIES COMMERCIAUX LANCENT LE « FORUM REGLEMENTAIRE DE LA LIG…
|
French | 81.2 KB | ||
| 2011-09-06 17:40 |
VIVALIS AND ITS COMMERCIAL LICENSEES LAUNCH THE "EB66® CELL LINE REGULATORY FOR…
|
English | 85.3 KB | ||
| 2011-09-05 17:46 |
VIVALIS ACTIONS ET DROITS DE VOTE
|
English | 51.7 KB | ||
| 2011-08-30 17:45 |
VIVALIS COMPTES SEMESTRIELS
|
French | 454.4 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
